Hot Products

2',3,5,6',7-Pentahydroxyflavanone
Catalog No: CFN97277

(2R,3R)-2',3,5,6'7-pentahydroxyflavanone(2',3,5,6',7-Pentahydroxyflavanone) can inhibit the histamine release from rat mast cells induced by compound 48/80. It inhibits the lipid peroxide formation by Feand ascorbic acid, it also inhibits the lipid peroxide formation induced by adenosine diphosphate and reduces nicotinamide adenine dinucleotide phosphate in rat liver homogenate.

2,3,8-Tri-O-methylellagic acid
Catalog No: CFN99680

2,3,8-tri-O-Methyl ellagic acid has antimicrobial activity agaist Vibro cholera, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacillus cereus, Escherichia coli.

2,3-Bis(3,4-dimethoxybenzyl)butyrolactone
Catalog No: CFN98281

trans-2,3-Bis(3,4-dimethoxybenzyl)-gamma-butyrolactone is capable of inhibiting Na+,K+-ATPase activity with IC50 at a concentration less than 5 x 10(-4) M, it also shows [3H]ouabain displacement activity with IC50 at a concentration of 10(-4)-10(-3) M.

2,3-Dehydrokievitone
Catalog No: CFN97223

2,3- Dehydrokievitone exhibits strong cytotoxic activity and induces apoptosis efficiently in cancer cells.

2,3-Dehydrosilybin A
Catalog No: CFN70322

2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound.

2,3-Dehydrosilybin B
Catalog No: CFN70271

2,3-Dehydrosilybin B inhibits Aβ aggregation.

2,3-Dehydrosilychristin
Catalog No: CFN95370

2,3-Dehydrosilychristin might have a biologically relevant inhibitory effect on ADH and glutamate dehydrogenase.2,3-Dehydrosilychristin is highly protective against copper-induced erythrocyte lysis .2,3-Dehydrosilychristin has antioxidant properties。

2,3-Didehydrosomnifericin
Catalog No: CFN91969

Reference standards.

2,3-Dihydroxy-12-oleanen-28-oic acid
Catalog No: CFN98310

2,3-Dihydroxy-olean-12-en-28-oic acids show a low cytotoxicity towards several human tumor cell lines.

2,4,5-Trimethoxybenzaldehyde
Catalog No: CFN98680

2,4,5-Trimethoxybenzaldehyde (2,4,5-TMBA) has anti-adipogenic potential, is a natural cyclooxygenase II (COX-2) inhibitor, suppresses the differentiation of preadipocyts into adipocytes at the concentration of 0.5 mM.